down arrow

Beijing Scitop Bio-Tech Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100004181
CNY
17.38
0.8 (4.83%)

Dec 05

SHE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Beijing Scitop Bio-Tech Co., Ltd.
Why is Beijing Scitop Bio-Tech Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 0.85% and Operating profit at -6.48% over the last 5 years
2
Positive results in Mar 25
  • RAW MATERIAL COST(Y) Fallen by 1.33% (YoY)
  • CASH AND EQV(HY) Highest at CNY 1,754.04 MM
  • DEBT-EQUITY RATIO (HY) Lowest at -50.79 %
3
With ROE of 5.06%, it has a expensive valuation with a 0.79 Price to Book Value
  • Over the past year, while the stock has generated a return of 11.80%, its profits have fallen by -5.9%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Beijing Scitop Bio-Tech Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Beijing Scitop Bio-Tech Co., Ltd. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Beijing Scitop Bio-Tech Co., Ltd.
-100.0%
0.38
55.79%
China Shanghai Composite
15.19%
1.01
15.10%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
0.85%
EBIT Growth (5y)
-6.48%
EBIT to Interest (avg)
86.97
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.51
Sales to Capital Employed (avg)
0.18
Tax Ratio
14.14%
Dividend Payout Ratio
41.89%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.24%
ROE (avg)
7.69%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
0.79
EV to EBIT
7.36
EV to EBITDA
5.09
EV to Capital Employed
0.59
EV to Sales
1.67
PEG Ratio
NA
Dividend Yield
2.80%
ROCE (Latest)
7.98%
ROE (Latest)
5.06%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
RAW MATERIAL COST(Y)

Fallen by 1.33% (YoY

CASH AND EQV(HY)

Highest at CNY 1,754.04 MM

DEBT-EQUITY RATIO (HY)

Lowest at -50.79 %

INVENTORY TURNOVER RATIO(HY)

Highest at 3.7%

DEBTORS TURNOVER RATIO(HY)

Highest at 5.5%

NET SALES(Q)

At CNY 77 MM has Grown at 31.77%

-5What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at CNY 112.87 MM

OPERATING PROFIT(Q)

Lowest at CNY 16.26 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 21.12 %

Here's what is working for Beijing Scitop Bio-Tech Co., Ltd.
Net Sales
At CNY 77 MM has Grown at 31.77%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Cash and Eqv
Highest at CNY 1,754.04 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio
Lowest at -50.79 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Inventory Turnover Ratio
Highest at 3.7%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio
Highest at 5.5%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by 1.33% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Beijing Scitop Bio-Tech Co., Ltd.
Operating Cash Flow
Lowest at CNY 112.87 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Operating Profit
Lowest at CNY 16.26 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin
Lowest at 21.12 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."